Biobot Analytics, Inc.
Biotechnology company · Somerville, Massachusetts, United States
Biobot Analytics, Inc. is a biotechnology company headquartered in Somerville, Massachusetts, United States. Its earliest recorded incorporation is in 2017. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $1.5 million in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $6.7 million sold in a notice filed in 2020.
Biobot Analytics at a glance
What does Biobot Analytics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $1.5 million in total (2020 to 2021). NIH funding came from the National Institute on Drug Abuse.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $6.7 million sold (2020).
Frequently asked questions about Biobot Analytics
Where is Biobot Analytics headquartered?
Biobot Analytics, Inc. is headquartered in Somerville, Massachusetts, United States.
What does Biobot Analytics do?
Biobot Analytics, Inc. is a biotechnology company.
When was Biobot Analytics founded?
The earliest incorporation on record for Biobot Analytics, Inc. is in 2017, according to public company registers.
Similar companies
- Promakhos Therapeutics Inc.Somerville, Massachusetts, United States
- Metera Pharmaceuticals Inc.Somerville, Massachusetts, United States
- bluebird bio, Inc.Somerville, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences